Investing in Better Future
STRATEGY
Our focus is on company’s management and its technological breakthroughs. Such discipline enables us to invest in a wide range of companies, ranging from early-stage ventures to pre-IPO or even public equities.
As a part of DongKoo Bio & Pharma, we try to utilize our knowhows and network in bio and pharmaceutical industry for our investments. Furthermore, we seek to benefit from the global universe of companies with technological breakthroughs and convergence.
Our long-term investment approach aims to add value in invested companies to help its growth with right strategy and resources.
Investment Philosophy
Lofty Ambition
we continuously challenge ourselves to achieve the consistent returns no matter what the market condition is
Rock Solid
we try to minimize our investment risk through preemptive risk management and balanced portfolio
Contrarian
we try to find value by being free from the market sentiment
Game Changer
we invest in companies with disruptive technologies that will transform the industry
In order to provide consistent returns for our investors, we try to build a balanced portfolio considering for different risk exposures, such as investment stages, sectors, currency, and etc. For sectors, we focus on both biotechnology and non-biotechnology sectors with technological breakthroughs and convergence.